# Clonidine

Drug · id `cardio:clonidine` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Clonidine hydrochloride

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

Clonidine is a central alpha-2 agonist, a medicine that acts on the brain stem to lower blood pressure. The US label read, for generic clonidine hydrochloride tablets taken by mouth, lists the treatment of hypertension, alone or together with other blood pressure medicines. The label says it stimulates alpha-adrenoreceptors in the brain stem, which reduces sympathetic outflow (nerve signals of the sympathetic system) from the central nervous system.

## Technical summary

RxNorm ingredient 2599 (clonidine hydrochloride is 142432); UNII W76I6XXF06 is the UNII of the hydrochloride salt that the label gives, so it is a broad match. MeSH descriptor D003000 is Clonidine. RxClass lists the FDA established pharmacologic class Central alpha-2 Adrenergic Agonist; the record is filed under the class page for alpha-adrenergic blockers and central alpha-2 agonists on that evidence. The label read is the Unichem Pharmaceuticals (USA), Inc. generic tablet label, application ANDA078895, effective 2026-03-30 in openFDA. The plan row pointed at a repackager label (RemedyRepack); the manufacturer's label replaces it. The transdermal system (Catapres-TTS, read for the class page), the injection and the combination products that contain clonidine were not read. This page records the label indication, the class sentence and the mechanism sentence only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People with hypertension, as described in the US label of generic clonidine hydrochloride tablets

Recipient: Recipient not specified; Population: Patients with hypertension, as the indications section of the label states. The label passages read do not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of clonidine hydrochloride tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA078895; the version dated 2026-03-30 in openFDA) lists the treatment of hypertension, and says the tablets may be used alone or together with other antihypertensive agents. It calls clonidine hydrochloride a centrally acting alpha-agonist hypotensive agent and says it stimulates alpha-adrenoreceptors in the brain stem, which reduces sympathetic outflow from the central nervous system.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients with hypertension, as the indications section of the label states. The label passages read do not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for a generic oral tablet; the transdermal system, the injection and the combination products that contain clonidine were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-18
- Sources:
  1. Background: openFDA drug label record for clonidine hydrochloride tablets, Unichem Pharmaceuticals (USA), Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 21bfa28f-20df-43fd-bb80-b720d3b40696 (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA078895), returned on 2026-11-18. The label text is dated 2026-03-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2221bfa28f-20df-43fd-bb80-b720d3b40696%22&limit=1>
     Locator: results\[0\].openfda.application\_number\[0\]. Retrieved 2026-11-18T21:59:11Z. Source state: Current. Version fingerprint: 5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae.
     How it applies: Application number of the label read.
  2. Background: openFDA drug label record for clonidine hydrochloride tablets, Unichem Pharmaceuticals (USA), Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 21bfa28f-20df-43fd-bb80-b720d3b40696 (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA078895), returned on 2026-11-18. The label text is dated 2026-03-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2221bfa28f-20df-43fd-bb80-b720d3b40696%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-18T21:59:11Z. Source state: Current. Version fingerprint: 5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae.
     How it applies: Effective date of the label text read.
  3. Supports: openFDA drug label record for clonidine hydrochloride tablets, Unichem Pharmaceuticals (USA), Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 21bfa28f-20df-43fd-bb80-b720d3b40696 (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA078895), returned on 2026-11-18. The label text is dated 2026-03-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2221bfa28f-20df-43fd-bb80-b720d3b40696%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-11-18T21:59:11Z. Source state: Current. Version fingerprint: 5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae.
     How it applies: Label passage quoted in the research quote table (CLO-LB-04, CLO-LB-05).
  4. Supports: openFDA drug label record for clonidine hydrochloride tablets, Unichem Pharmaceuticals (USA), Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 21bfa28f-20df-43fd-bb80-b720d3b40696 (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA078895), returned on 2026-11-18. The label text is dated 2026-03-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2221bfa28f-20df-43fd-bb80-b720d3b40696%22&limit=1>
     Locator: results\[0\].description\[0\]. Retrieved 2026-11-18T21:59:11Z. Source state: Current. Version fingerprint: 5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae.
     How it applies: Label passage quoted in the research quote table (CLO-LB-06).
  5. Supports: openFDA drug label record for clonidine hydrochloride tablets, Unichem Pharmaceuticals (USA), Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 21bfa28f-20df-43fd-bb80-b720d3b40696 (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA078895), returned on 2026-11-18. The label text is dated 2026-03-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2221bfa28f-20df-43fd-bb80-b720d3b40696%22&limit=1>
     Locator: results\[0\].clinical\_pharmacology\[0\]. Retrieved 2026-11-18T21:59:11Z. Source state: Current. Version fingerprint: 5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae.
     How it applies: Label passage quoted in the research quote table (CLO-LB-07).

## Connected pages

- Clonidine is a central alpha-2 adrenergic agonist (FDA established pharmacologic class in RxClass): Alpha-adrenergic blockers and central alpha-2 agonists (`cardio:alpha-adrenergic-blockers-and-central-alpha-2-agonists`)
- FDA label lists the treatment of hypertension, alone or with other antihypertensive agents, as the indication: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-clonidine-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Provenance

Content hash: 1bdbad51d653e4596e8dfa2014d450e99f2575c23fa3e1246094ae24c38c3373
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
